vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and SYPRIS SOLUTIONS INC (SYPR). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $30.3M, roughly 1.6× SYPRIS SOLUTIONS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -12.9%, a 8.1% gap on every dollar of revenue. On growth, SYPRIS SOLUTIONS INC posted the faster year-over-year revenue change (-9.5% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-1.5M). Over the past eight quarters, SYPRIS SOLUTIONS INC's revenue compounded faster (-7.7% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.
IRWD vs SYPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $30.3M |
| Net Profit | $-2.3M | $-3.9M |
| Gross Margin | — | 4.6% |
| Operating Margin | 14.3% | -10.9% |
| Net Margin | -4.8% | -12.9% |
| Revenue YoY | -47.3% | -9.5% |
| Net Profit YoY | -200.9% | -2992.6% |
| EPS (diluted) | $0.01 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $30.3M | ||
| Q3 25 | $122.1M | $28.7M | ||
| Q2 25 | $85.2M | $31.4M | ||
| Q1 25 | $41.1M | $29.5M | ||
| Q4 24 | $90.5M | $33.4M | ||
| Q3 24 | $91.6M | $35.7M | ||
| Q2 24 | $94.4M | $35.5M | ||
| Q1 24 | $74.9M | $35.6M |
| Q4 25 | $-2.3M | $-3.9M | ||
| Q3 25 | $40.1M | $517.0K | ||
| Q2 25 | $23.6M | $-2.1M | ||
| Q1 25 | $-37.4M | $-899.0K | ||
| Q4 24 | $2.3M | $135.0K | ||
| Q3 24 | $3.6M | $390.0K | ||
| Q2 24 | $-860.0K | $16.0K | ||
| Q1 24 | $-4.2M | $-2.2M |
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | — | 8.2% | ||
| Q1 25 | — | 11.4% | ||
| Q4 24 | — | 16.1% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | — | 15.9% | ||
| Q1 24 | — | 8.1% |
| Q4 25 | 14.3% | -10.9% | ||
| Q3 25 | 61.8% | -6.1% | ||
| Q2 25 | 53.2% | -4.6% | ||
| Q1 25 | -70.7% | -0.4% | ||
| Q4 24 | 34.8% | 3.9% | ||
| Q3 24 | 28.0% | 4.8% | ||
| Q2 24 | 26.5% | 3.6% | ||
| Q1 24 | 14.7% | -3.9% |
| Q4 25 | -4.8% | -12.9% | ||
| Q3 25 | 32.8% | 1.8% | ||
| Q2 25 | 27.7% | -6.5% | ||
| Q1 25 | -90.9% | -3.0% | ||
| Q4 24 | 2.5% | 0.4% | ||
| Q3 24 | 4.0% | 1.1% | ||
| Q2 24 | -0.9% | 0.0% | ||
| Q1 24 | -5.6% | -6.2% |
| Q4 25 | $0.01 | $-0.17 | ||
| Q3 25 | $0.23 | $0.02 | ||
| Q2 25 | $0.14 | $-0.09 | ||
| Q1 25 | $-0.23 | $-0.04 | ||
| Q4 24 | $0.03 | $0.00 | ||
| Q3 24 | $0.02 | $0.02 | ||
| Q2 24 | $-0.01 | $0.00 | ||
| Q1 24 | $-0.03 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $17.8M |
| Total Assets | $396.9M | $107.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | — | ||
| Q3 25 | $140.4M | — | ||
| Q2 25 | $92.9M | — | ||
| Q1 25 | $108.5M | — | ||
| Q4 24 | $88.6M | — | ||
| Q3 24 | $88.2M | — | ||
| Q2 24 | $105.5M | — | ||
| Q1 24 | $121.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $17.8M | ||
| Q3 25 | $-264.2M | $20.0M | ||
| Q2 25 | $-308.2M | $18.7M | ||
| Q1 25 | $-334.1M | $19.0M | ||
| Q4 24 | $-301.3M | $19.6M | ||
| Q3 24 | $-311.3M | $18.2M | ||
| Q2 24 | $-321.7M | $19.0M | ||
| Q1 24 | $-330.5M | $20.8M |
| Q4 25 | $396.9M | $107.8M | ||
| Q3 25 | $396.1M | $112.5M | ||
| Q2 25 | $342.9M | $105.8M | ||
| Q1 25 | $327.2M | $110.2M | ||
| Q4 24 | $350.9M | $119.4M | ||
| Q3 24 | $389.5M | $121.6M | ||
| Q2 24 | $395.6M | $124.2M | ||
| Q1 24 | $438.8M | $129.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $-1.1M |
| Free Cash FlowOCF − Capex | $74.6M | $-1.5M |
| FCF MarginFCF / Revenue | 156.3% | -5.0% |
| Capex IntensityCapex / Revenue | 0.0% | 1.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $-6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $-1.1M | ||
| Q3 25 | $47.6M | $-178.0K | ||
| Q2 25 | $-15.1M | $1.1M | ||
| Q1 25 | $20.0M | $-5.5M | ||
| Q4 24 | $15.2M | $2.3M | ||
| Q3 24 | $9.9M | $-4.8M | ||
| Q2 24 | $33.5M | $6.2M | ||
| Q1 24 | $45.0M | $-1.7M |
| Q4 25 | $74.6M | $-1.5M | ||
| Q3 25 | $47.6M | $-390.0K | ||
| Q2 25 | $-15.1M | $941.0K | ||
| Q1 25 | $19.9M | $-5.5M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | $9.9M | $-4.9M | ||
| Q2 24 | $33.4M | $6.0M | ||
| Q1 24 | $44.9M | $-2.0M |
| Q4 25 | 156.3% | -5.0% | ||
| Q3 25 | 39.0% | -1.4% | ||
| Q2 25 | -17.7% | 3.0% | ||
| Q1 25 | 48.4% | -18.8% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | 10.8% | -13.8% | ||
| Q2 24 | 35.4% | 16.8% | ||
| Q1 24 | 60.0% | -5.7% |
| Q4 25 | 0.0% | 1.3% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.5% | ||
| Q1 25 | 0.1% | 0.0% | ||
| Q4 24 | 0.0% | 1.2% | ||
| Q3 24 | 0.0% | 0.4% | ||
| Q2 24 | 0.1% | 0.5% | ||
| Q1 24 | 0.1% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | -0.34× | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | 17.13× | ||
| Q3 24 | 2.71× | -12.21× | ||
| Q2 24 | — | 385.25× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
SYPR
| Sypris Electronics | $17.7M | 59% |
| Transferred At Point In Time | $12.5M | 41% |
